Search Results

By Elizabeth R. Gerstner, MD  / October 15, 2014

Failure of Cilengitide in Newly Diagnosed Glioblastoma With Methylated MGMT Promoter

Temozolomide in combination with radiation for newly diagnosed glioblastoma was approved by the U.S. Food and Drug Administration in 2005—almost 10 years ago—but we have unfortunately made little progress in improving survival for this incurable brain tumor. Despite recent completion of three...